Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00137631 · ClinicalTrials.gov registry record · Phase 1
Evaluation of Many Men, Many Voices, An STD/HIV Prevention Intervention for Black MSM
A Phase 1 study of HIV Infections and Sexually Transmitted Diseases, sponsored by Centers for Disease Control and Prevention.
- Completed
- Registry status
- Phase 1
- Development phase
- 341
- Enrollment target
- 1
- Study location
NCT00137631: Completed Phase 1 study of HIV Infections and Sexually Transmitted Diseases, sponsored by Centers for Disease Control and Prevention.
NCT00137631 is a Phase 1 study of HIV Infections and Sexually Transmitted Diseases that has completed, run by Centers for Disease Control and Prevention. The registered enrollment target is 341 participants, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (23% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00137631, a Phase 1 study of HIV Infections and Sexually Transmitted Diseases, has completed, sponsored by Centers for Disease Control and Prevention.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 341 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this program evaluation is to determine whether the "Many Men, Many Voices" HIV/STD prevention intervention is effective in reducing HIV sex risk behaviors and increasing HIV testing among African-American men who have sex with men (MSM), who may or may not self-identify as gay. The intent of this program is to support the evaluation of an existing intervention and provide feedback to the implementing organization for improved program effectiveness, not to conduct research.
Primary Outcome
Sexual activities with casual male partners in past 3 months (i.e., any unprotected insertive or receptive anal sex)
Conditions Studied
Interventions
- BEHAVIORAL Many Men, Many Voices (3MV)
Study Locations (1)
New York
- People of Color in Crisis, Inc. - Brooklyn
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 341 participants |
| Start Date | 2005-08 |
| Est. Completion | 2007-08 |
| Phase | Phase 1 |
What the finished NCT00137631 record still lists
NCT00137631 is an interventional study that assigns participants to a tested intervention. The registered 341 participants enrollment target is mid-sized for trials with a published cap, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (23% lower).
The record links to 2 conditions, with HIV Infections appearing as the primary indexed condition, and to 1 intervention - of which Many Men, Many Voices (3MV) is the first listed.
NCT00137631 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT00137631 about?
NCT00137631 is a clinical study titled "Evaluation of Many Men, Many Voices, An STD/HIV Prevention Intervention for Black MSM". The purpose of this program evaluation is to determine whether the "Many Men, Many Voices" HIV/STD prevention intervention is effective in reducing HIV sex risk behaviors and increasing HIV testing among African-American men who have sex with men (MSM), who may or may not self-identify as gay. The i...
What is the current status of trial NCT00137631?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 341 participants. The study started on 2005-08. Estimated completion is 2007-08.
What conditions does trial NCT00137631 study?
This clinical trial studies the following conditions: HIV Infections, Sexually Transmitted Diseases.
What interventions are being tested in trial NCT00137631?
The interventions under investigation include: Many Men, Many Voices (3MV) (BEHAVIORAL).
Who is sponsoring clinical trial NCT00137631?
This trial is sponsored by Centers for Disease Control and Prevention, which has 139 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00137631 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00137631's enrollment target sits among peer trials
341 103rd of 542 higher than 440 of 542 other HIV Infections trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
CAR-T Cells for HIV Infection
RECRUITING · Phase 1
-
A Study to Investigate the Use of VH3810109 With or Without Fostemsavir (FTR) to Reduce the Size and Activity of the Viral Reservoir in People Living With HIV
RECRUITING · Phase 1
-
Clinical Trial to Evaluate the Safety and Immunogenicity of Hiltonol, Poly-ICLC-adjuvanted CD40.HIVRI.Env (VRIPRO) in Adult Participants Who Previously Participated in HVTN 706
RECRUITING · Phase 1
-
Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics
RECRUITING · Phase 1
-
A Study to Investigate Pharmacokinetics, Safety and Tolerability of Long-Acting Cabotegravir Plus Recombinant Human Hyaluronidase PH20 in Healthy Adult Participants
RECRUITING · Phase 1
-
First Time in Human Study of Long Acting VH4524184 Formulations
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06852170 · 341 participants · NA
Data2Action Oregon Project: Supporting Data-driven Decision-Making for Substance Use Services, Policy, and Overdose Prevention
- NCT05283850 · 342 participants · Phase 2
Surviving PEA in Roanoke (SPEAR) Study
- NCT05714085 · 342 participants · Phase 2
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
- NCT06188702 · 342 participants · Phase 1
S095035 as a Single Agent and in Combination in Adult Participants With Advanced or Metastatic Solid Tumors With Deletion of MTAP
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia